| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = $107,166 ) |
| | 2024 | 2024 | ELGIA THERAPEUTICS, INC. | 10686 HUNTERS GLEN DR | SAN DIEGO | CA | 92130-4850 | SAN DIEGO | USA | R41AG078036 | Optimizing brain penetrance of caspase-6 inhibitors to treat neurodegenerative diseases | 001 | 2 | NIH | 8/29/2024 | $107,166 |
| | 2024 | 2023 | ELGIA THERAPEUTICS, INC. | 10686 HUNTERS GLEN DR | SAN DIEGO | CA | 92130-4850 | SAN DIEGO | USA | R41AG078036 | Optimizing brain penetrance of caspase-6 inhibitors to treat neurodegenerative diseases | 000 | 1 | NIH | 10/24/2023 | $0 |
|
| Issue Date FY: 2023 ( Subtotal = $180,375 ) |
| | 2023 | 2023 | ELGIA THERAPEUTICS, INC. | 10686 HUNTERS GLEN DR | SAN DIEGO | CA | 92130-4850 | SAN DIEGO | USA | R41AG078036 | Optimizing brain penetrance of caspase-6 inhibitors to treat neurodegenerative diseases | 000 | 1 | NIH | 9/22/2023 | $180,375 |
|
|
